[Pharmacological action of antipsychotic drugs].
Tokuda
Kumiko
K
kumiko-tokuda@ds-pharma.co.jp
D058668:Adrenergic alpha-1 Receptor Antagonists; D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology*; D065127:Dopamine D2 Receptor Antagonists; D015195:Drug Design; D006634:Histamine H1 Antagonists; D006801:Humans; D043643:Receptor, Muscarinic M1 / Q000037:antagonists & inhibitors; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology; D058825:Serotonin 5-HT1 Receptor Agonists; D058830:Serotonin 5-HT2 Receptor Antagonists
D058668:Adrenergic alpha-1 Receptor Antagonists; D014150:Antipsychotic Agents; D065127:Dopamine D2 Receptor Antagonists; D006634:Histamine H1 Antagonists; D043643:Receptor, Muscarinic M1; D016194:Receptors, N-Methyl-D-Aspartate; D058825:Serotonin 5-HT1 Receptor Agonists; D058830:Serotonin 5-HT2 Receptor Antagonists